You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition

Article info

Article menu

Download PDFPDF

XML
Research Article
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition

Authors

  • Xuanye Zhang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Yixin Zhou State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of VIP regionSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Chen Chen State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of RadiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Wenfeng Fang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Xiuyu Cai State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of VIP regionSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Xiaoshi Zhang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Biotherapy CenterSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Ming Zhao State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Minimally Invasive Interventional Radiology, Center of Medical Imaging and Interventional RadiologySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Bei Zhang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of VIP regionSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Wenqi Jiang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Zuan Lin State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Clinical ResearchSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Yuxiang Ma State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Clinical ResearchSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Yunpeng Yang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Yan Huang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Hongyun Zhao State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Clinical ResearchSun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Ruihua Xu State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Shaodong Hong State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  • Li Zhang State Key Laboratory of Oncology in South China Guangzhou China Collaborative Innovation Center for Cancer Medicine Guangzhou China Department of Medical OncologySun Yat-sen University Cancer Center 651 Dongfeng East Road 510060 Guangzhou China PubMed articlesGoogle scholar articles
  1. ↵o xurh{at}sysucc.org.cn
  2. ↵p hongshd{at}sysucc.org.cn
  3. ↵q zhangli6{at}mail.sysu.edu.cn
View Full Text

Citation

Zhang X, Zhou Y, Chen C, et al
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
Journal for ImmunoTherapy of Cancer 2019;7:322. doi: 10.1186/s40425-019-0808-5

Publication history

  • Received August 23, 2019
  • Accepted November 6, 2019
  • First published November 21, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.